Andrew L. Finn,Pharm.D
2014
In 2014, Andrew L. Finn,Pharm.D earned a total compensation of $1.8M as Executive VP of Product Development at BioDelivery Sciences International, a 61% increase compared to previous year.
Compensation breakdown
| Bonus | $127,140 |
|---|---|
| Salary | $307,013 |
| Stock Awards | $1,365,995 |
| Other | $38,958 |
| Total | $1,839,106 |
FinnPharmD received $1.4M in stock awards, accounting for 74% of the total pay in 2014.
FinnPharmD also received $127.1K in bonus, $307K in salary and $39K in other compensation.
Rankings
In 2014, Andrew L. Finn,Pharm.D's compensation ranked 4,866th out of 13,032 executives tracked by ExecPay. In other words, FinnPharmD earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,866 out of 13,032 | 63rd |
Division Manufacturing | 1,740 out of 4,966 | 65th |
Major group Chemicals And Allied Products | 570 out of 1,686 | 66th |
Industry group Drugs | 435 out of 1,365 | 68th |
Industry Pharmaceutical Preparations | 346 out of 1,043 | 67th |
Source: SEC filing on June 5, 2015.
FinnPharmD's colleagues
We found six more compensation records of executives who worked with Andrew L. Finn,Pharm.D at BioDelivery Sciences International in 2014.
2014
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
2014
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
2014
Andrew Finn
BioDelivery Sciences International
Executive VP of Product Development
2014
Niraj Vasisht
BioDelivery Sciences International
Chief Technology Officer
2014
Ernest De Paolantonio
BioDelivery Sciences International
Chief Financial Officer
2014
Ernest De PaolantonioCPA
BioDelivery Sciences International